As of 2025-05-20, the Intrinsic Value of NervGen Pharma Corp (NGEN.V) is -1.69 CAD. This NGEN.V valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.68 CAD, the upside of NervGen Pharma Corp is -136.01%.
Based on its market price of 4.68 CAD and our intrinsic valuation, NervGen Pharma Corp (NGEN.V) is overvalued by 136.01%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.69 - -1.69 | -1.69 | -136.01% |
| DDM - Stable | (3.80) - (55.52) | (29.66) | -733.8% |
| DDM - Multi | (3.54) - (42.23) | (6.67) | -242.4% |
| Market Cap (mil) | 333.36 |
| Beta | -0.41 |
| Outstanding shares (mil) | 71.23 |
| Enterprise Value (mil) | 316.19 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.38% |
| Cost of Debt | 5.00% |
| WACC | 7.37% |